Scott Gottlieb — SPARQNOW

At-a-Glance

Served as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from May 2017 until April 2019.
Partner at New Enterprise Associates (NEA), a venture capital firm, since 2007.
Chairman of the Board of Directors at Illumina since 2020 and an Independent Member of the Board of Directors at Pfizer since 2019.
Author of the New York Times bestseller 'Uncontrolled Spread' and 'The Miracle Century: Making Sense of the Cell Therapy Revolution.'
Senior Fellow at the American Enterprise Institute since 2003 and an elected member of the National Academy of Medicine since 2018.
Holds a Doctor of Medicine (MD) from Icahn School of Medicine at Mount Sinai and a bachelor's degree in economics from Wesleyan University.

Biography

Scott Gottlieb, MD, is a physician and investor known for his work in public health and healthcare innovation. He currently serves as a Partner at New Enterprise Associates (NEA), a venture capital firm, a Senior Fellow at the American Enterprise Institute (AEI), and holds significant board positions, including Chairman of the Board of Directors at Illumina and an Independent Member of the Board of Directors at Pfizer. Dr.

Gottlieb previously served as the 23rd Commissioner of the U.S.